Home > Journals > Physiotherapy and Occupational Therapy Journal

Physiotherapy and Occupational Therapy Journal

Submit your article Read this Journals View all journals
Full Text (PDF)
Original Article

Combination of Methocarbamol and Diclofenac: A New Solution for Treating Low Back Pain

Nilesh Shah , 1Nilesh Shah , 2Shaival Dalal

Author Information

Licence:



Physiotherapy and Occupational Therapy Journal 14(3):p 22-26, July-september 2021. | DOI: http://dx.doi.org/10.21088/potj.0974.5777.14321.3

How Cite This Article:

Nilesh Shah, Shaival Dalal Combination of Methocarbamol and Diclofenac: A New Solution for Treating Low Back Pain. Phy -siotherapy and Occupational Therapy Journal. 2021; 14(3):22-27

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Introduction: Lower back pain (LBP) is a condition that restricts occupational activities of the patients suffering from it owing to pain and its perception, thus severely impacting functional capacity. The economic burden of LBP could be represented directly by the high costs of health care that one has to spend for the symptomatic relief from pain and indirectly due to decreased productivity owing to absenteeism. Material & Method: LBP can be acute, subacute or chronic in duration, however, with conservative measures that includes timely diagnosis and right treatment, the symptoms of low back pain typically improved within a few weeks from onset. Common attributes of LBP are muscular tension and spasms. Result: Pharmacological interventions for the treatment of LBP generally includes non-steroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants, wherein both muscle relaxants and NSAIDs have proven efficacy and safety. Studies have shown that combining NSAIDs with a muscle relaxant could be a better treatment option than NSAIDs alone. One such example is Robi D, which is a combination of muscle relaxant methocarbamol and NSAID diclofenac, indicated for the relief of pain and inflammation associated with LBP along with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis. Conclusion: Although there are no individual studies that have assessed the efficacy and safety of Robi D, the individual efficacy and safety of its components speaks volumes of its durability both in real world and clinical trial. Robi D Injection may be administered during acute or severe phase up to a maximum of 3 days or less until amelioration of acute symptoms, post while the patients could be kept on a maintenance therapy with oral Robinaxol D tablets that contain methocarbamol (muscle relaxant) + diclofenac potassium (analgesic) + paracetamol (analgesic).

Keywords: Methocarbamol; Diclofenac; Low Back Pain.

References

No records found.


About this article

Cite this article

Nilesh Shah, Shaival Dalal Combination of Methocarbamol and Diclofenac: A New Solution for Treating Low Back Pain. Phy -siotherapy and Occupational Therapy Journal. 2021; 14(3):22-27

Licence:



Received Accepted Published
N/A N/A N/A
DOI: http://dx.doi.org/10.21088/potj.0974.5777.14321.3

Keywords


Article Level Metrics

Last Updated

Wednesday 29 July 2026, 20:57:44 (IST)

1979

Accesses

3
429
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share